Investor Alert: Galectin Therapeutics Inc. (NASDAQ:GALT) Under Investigation over Potential Violations of Federal Securities Laws

San Diego, CA -- (ReleaseWire) -- 03/25/2015 -- An investigation on behalf of investors of Galectin Therapeutics Inc. (NASDAQ:GALT) shares over potential securities laws violations by Galectin Therapeutics Inc. and certain of its directors and officers in connection certain financial statements was announced.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.